30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Gheuens Sarah

Track

Insider profile

Gheuens Sarah's trades of Agios Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-06 2026-04-02
PlS Planned sale
7,223 -46.1%
188.57
US$235,621 		7,223 -46.1% 188.57 US$235,621
2026-04-02 2026-04-02
PrS Proposed sale
77,531
339.03
US$926,329 		77,531 339.03 US$926,329
2026-03-03 2026-03-02
PlS Planned sale
22,726 -44.0%
427.51
US$794,399 		22,726 -44.0% 427.51 US$794,399
2026-03-03 2026-03-02
PlS Planned sale
1,681 -2.3%
28.96
US$48,682 		1,681 -2.3% 28.96 US$48,682
2026-03-03 2026-03-02
PlS Planned sale
1,187 -1.7%
28.96
US$34,376 		1,187 -1.7% 28.96 US$34,376
2026-03-02 2026-03-02
PrS Proposed sale
4,055
30.23
US$122,583 		4,055 30.23 US$122,583
2026-01-02 2025-12-30
PlS Planned sale
2,932 -4.3%
27.09
US$79,428 		2,932 -4.3% 27.09 US$79,428
2025-12-30 2025-12-30
PrS Proposed sale
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-11-13 2025-11-11
PlS Planned sale
2,454 -3.8%
43.78
US$107,436 		2,454 -3.8% 43.78 US$107,436
2025-11-12 2025-11-11
PrS Proposed sale
2,454
43.78
US$107,441 		2,454 43.78 US$107,441
2025-11-03 2025-10-30
PlS Planned sale
200 -0.3%
43.81
US$8,762 		200 -0.3% 43.81 US$8,762
2025-10-30 2025-10-30
PrS Proposed sale
200
43.81
US$8,762 		200 43.81 US$8,762
2025-10-29 2025-10-27
PlS Planned sale
3,302 -5.1%
43.92
US$145,024 		3,302 -5.1% 43.92 US$145,024
2025-10-27 2025-10-27
PrS Proposed sale
3,302
43.92
US$145,028 		3,302 43.92 US$145,028
2025-07-11 2025-07-09
PlS Planned sale
847 -1.4%
38.76
US$32,830 		847 -1.4% 38.76 US$32,830
2025-07-11 2025-07-09
PlS Planned sale
11,067 -15.1%
37.93
US$419,771 		11,067 -15.1% 37.93 US$419,771
2025-07-09 2025-07-09
PrS Proposed sale
11,914
37.99
US$452,632 		11,914 37.99 US$452,632
2025-07-03 2025-07-01
PlS Planned sale
4,091 -6.3%
34.17
US$139,789 		4,091 -6.3% 34.17 US$139,789
2025-07-01 2025-07-01
PrS Proposed sale
4,091
34.37
US$140,608 		4,091 34.37 US$140,608
2025-06-26 2025-06-24
PlS Planned sale
2,909 -4.9%
33.54
US$97,568 		2,909 -4.9% 33.54 US$97,568
2025-06-24 2025-06-24
PrS Proposed sale
1,761
34.41
US$60,596 		1,761 34.41 US$60,596
2025-03-04 2025-03-03
PlS Planned sale
1,681 -3.0%
35.54
US$59,743 		1,681 -3.0% 35.54 US$59,743
2025-03-04 2025-03-03
PlS Planned sale
1,187 -2.3%
35.54
US$42,186 		1,187 -2.3% 35.54 US$42,186
2025-03-04 2025-03-03
PlS Planned sale
1,137 -2.4%
35.54
US$40,409 		1,137 -2.4% 35.54 US$40,409
2025-03-03 2025-03-03
PrS Proposed sale
4,005
35.54
US$142,338 		4,005 35.54 US$142,338
2024-07-03 2024-07-01
PlS Planned sale
3,705 -7.8%
43.85
US$162,464 		3,705 -7.8% 43.85 US$162,464
2024-07-01 2024-07-01
PrS Proposed sale
3,705
43.85
US$162,464 		3,705 43.85 US$162,464
2024-03-05 2024-03-05
PlS Planned sale
1,349 -3.3%
32.57
US$43,937 		1,349 -3.3% 32.57 US$43,937
2024-03-05 2024-03-05
PlS Planned sale
1,293 -3.4%
32.57
US$42,113 		1,293 -3.4% 32.57 US$42,113
2024-03-01 2024-03-01
PrS Proposed sale
2,642
32.23
US$85,152 		2,642 32.23 US$85,152
2024-02-14 2024-02-14
PlS Planned sale
642 -1.9%
25.14
US$16,140 		642 -1.9% 25.14 US$16,140
2024-01-24 2024-01-24
PlS Planned sale
1,708 -5.1%
21.64
US$36,961 		1,708 -5.1% 21.64 US$36,961
2024-01-09 2024-01-09
PlS Planned sale
1,789 -6.0%
22.99
US$41,129 		1,789 -6.0% 22.99 US$41,129